Anthony Daniels

August 20, 2020

Hope On Wheels grant to enhance retinoblastoma research

Anthony Daniels, MD, MSc, has been awarded a $300,000 Hyundai Hope On Wheels Scholar Grant to study the design of more precise drugs to treat retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
September 8, 2016

The Alliance for Eye and Vision Research honors two from VEI

Two Vanderbilt Eye Institute physicians have been selected as Emerging Vision Scientists by the Alliance for Eye and Vision Research (AEVR).

By Jessica Pasley
July 21, 2016

Two receive Research to Prevent Blindness grants

Research to Prevent Blindness (RPB) has awarded two grants to faculty in the Department of Ophthalmology.

By Jessica Pasley
March 24, 2016

Gifts highlight strong, lasting bonds between patients and healers

Sometimes saying thank you just isn’t enough.

By Nancy Humphrey
June 25, 2015

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
October 9, 2014

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

By Jessica Pasley